Solitary Abdominal Wall Lymph Node Recurrence in Prostate Cancer Patient with Dramatic Prostate-Specific Antigen Decrease following Metastasectomy.


Journal

Case reports in urology
ISSN: 2090-696X
Titre abrégé: Case Rep Urol
Pays: United States
ID NLM: 101580193

Informations de publication

Date de publication:
2023
Historique:
received: 28 09 2022
revised: 15 01 2023
accepted: 25 01 2023
entrez: 23 2 2023
pubmed: 24 2 2023
medline: 24 2 2023
Statut: epublish

Résumé

Prostate cancer patients routinely undergo surveillance for recurrence using prostate-specific antigen (PSA). While PSA's benefit in screening is controversial, its use for detecting recurrence in patients with history of prostate cancer is pivotal. Rising PSAs with the newly advanced prostate-specific membrane antigen positron emission tomography (PSMA PET) can help localize the location of recurrences for better excision and management. Here, we present a 55-year-old with prostate cancer, with initially undetectable postprostatectomy PSA levels, who later presented with a PSA of 3.47 ng/mL. PSMA PET showed isolated uptake in an abdominal wall mass. Pelvic lymphadenectomy and abdominal wall mass excision were performed, confirming a single metastasis in an abdominal wall lymph node. Metastasectomy led to a dramatic drop in PSA to 0.10 ng/mL both postoperatively and on long-term follow-up. Our case illustrates the potential benefit of metastasis-directed therapy in delayed oligometastasis following definitive management of prostate cancer.

Identifiants

pubmed: 36818742
doi: 10.1155/2023/7301284
pmc: PMC9937751
doi:

Types de publication

Case Reports

Langues

eng

Pagination

7301284

Informations de copyright

Copyright © 2023 Andrew Williams et al.

Déclaration de conflit d'intérêts

The authors declare that they have no conflicts of interest.

Références

Eur Urol. 2015 May;67(5):852-63
pubmed: 25240974
Urol Int. 2018;100(3):251-262
pubmed: 29161715
JAMA Oncol. 2019 Jun 01;5(6):856-863
pubmed: 30920593
Urol Case Rep. 2017 Mar 11;12:42-44
pubmed: 28316937
Can Urol Assoc J. 2011 Dec;5(6):E104-8
pubmed: 22154171

Auteurs

Andrew Williams (A)

West Virginia University, School of Medicine, Morgantown, West Virginia, USA.

Amr A Elbakry (AA)

Urology Department, West Virginia University Hospital, Morgantown, West Virginia, USA.

Tyler Trump (T)

Urology Department, West Virginia University Hospital, Morgantown, West Virginia, USA.

Ion Prisneac (I)

Pathology Department, West Virginia University Hospital, Morgantown, West Virginia, USA.

Matthew Smolkin (M)

Pathology Department, West Virginia University Hospital, Morgantown, West Virginia, USA.

David Zekan (D)

Urology Department, West Virginia University Hospital, Morgantown, West Virginia, USA.

Mohamad W Salkini (MW)

Urology Department, West Virginia University Hospital, Morgantown, West Virginia, USA.

Classifications MeSH